Effects of cytisine on hydroxyl radicals in vitro and MPTP-induced dopamine depletion in vivo

被引:48
作者
Ferger, B
Spratt, C
Teismann, P
Seitz, G
Kuschinsky, K
机构
[1] Univ Marburg, Fac Pharm, Inst Pharmacol & Toxicol, D-35032 Marburg, Germany
[2] Univ Marburg, Fac Pharm, Inst Pharmaceut Chem, D-35032 Marburg, Germany
关键词
cytisine; iron-chelator; hydroxyl radical; Parkinson's disease; S-PBN; MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine;
D O I
10.1016/S0014-2999(98)00696-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The potential new iron-chelator cytisine and the radical scavenger N-tert-butyl-alpha-(2-sulfophenyl) nitrone (S-PBN) were incubated in a Fenton system and hydroxyl radical formation was measured with the salicylate trapping assay. Both cytisine and S-PBN reduced hydroxyl radical formation in a concentration-dependent manner. For in vivo studies, C57BL/6 mice were injected repeatedly with cytisine (0.5 mg/kg or 2.0 mg/kg s.c.) or saline seven days before and after a single 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) injection (30 mg/kg s.c.). Seven days after MPTP treatment alone dopamine levels were significantly reduced to 12% of the control values (p < 0.001), whereas MPTP + cytisine treatment (2 mg/kg) led to more than twofold higher dopamine levels (p < 0.01) compared with MPTP alone. We have shown fbr the first time that cytisine attenuates hydroxyl radical formation in vitro and reduces MPTP-induced dopamine depletion. Thus, cytisine may be useful for the treatment of Parkinson's Disease where the chelation of iron ions could prevent neuronal cell death. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:155 / 163
页数:9
相关论文
共 29 条
  • [1] THE IRON CHELATOR DESFERRIOXAMINE (DESFERAL) RETARDS 6-HYDROXYDOPAMINE-INDUCED DEGENERATION OF NIGROSTRIATAL DOPAMINE NEURONS
    BENSHACHAR, D
    ESHEL, G
    FINBERG, JPM
    YOUDIM, MBH
    [J]. JOURNAL OF NEUROCHEMISTRY, 1991, 56 (04) : 1441 - 1444
  • [2] INTRANIGRAL IRON INJECTION INDUCES BEHAVIORAL AND BIOCHEMICAL PARKINSONISM IN RATS
    BENSHACHAR, D
    YOUDIM, MBH
    [J]. JOURNAL OF NEUROCHEMISTRY, 1991, 57 (06) : 2133 - 2135
  • [3] Parkinson disease: A new link between monoamine oxidase and mitochondrial electron flow
    Cohen, G
    Farooqui, R
    Kesler, N
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) : 4890 - 4894
  • [4] OXIDATIVE STRESS, GLUTAMATE, AND NEURODEGENERATIVE DISORDERS
    COYLE, JT
    PUTTFARCKEN, P
    [J]. SCIENCE, 1993, 262 (5134) : 689 - 695
  • [5] DECREASED FERRITIN LEVELS IN BRAIN IN PARKINSONS-DISEASE
    DEXTER, DT
    CARAYON, A
    VIDAILHET, M
    RUBERG, M
    AGID, F
    AGID, Y
    LEES, AJ
    WELLS, FR
    JENNER, P
    MARSDEN, CD
    [J]. JOURNAL OF NEUROCHEMISTRY, 1990, 55 (01) : 16 - 20
  • [6] INCREASED NIGRAL IRON CONTENT AND ALTERATIONS IN OTHER METAL-IONS OCCURRING IN BRAIN IN PARKINSONS-DISEASE
    DEXTER, DT
    WELLS, FR
    LEES, AJ
    AGID, F
    AGID, Y
    JENNER, P
    MARSDEN, CD
    [J]. JOURNAL OF NEUROCHEMISTRY, 1989, 52 (06) : 1830 - 1836
  • [7] IRON-MEDIATED BIOACTIVATION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IN GLIAL CULTURES
    DIMONTE, DA
    SCHIPPER, HM
    HETTS, S
    LANGSTON, JW
    [J]. GLIA, 1995, 15 (02) : 203 - 206
  • [8] VERTEILUNG VON NORADRENALIN UND DOPAMIN (3-HYDROXYTYRAMIN) IM GEHIRN DES MENSCHEN UND IHR VERHALTEN BEI ERKRANKUNGEN DES EXTRAPYRAMIDALEN SYSTEMS
    EHRINGER, H
    HORNYKIEWICZ, O
    [J]. KLINISCHE WOCHENSCHRIFT, 1960, 38 (24): : 1236 - 1239
  • [9] EXPRESSION OF LACTOFERRIN RECEPTORS IS INCREASED IN THE MESENCEPHALON OF PATIENTS WITH PARKINSON DISEASE
    FAUCHEUX, BA
    NILLESSE, N
    DAMIER, P
    SPIK, G
    MOUATTPRIGENT, A
    PIERCE, A
    LEVEUGLE, B
    KUBIS, N
    HAUW, JJ
    AGID, Y
    HIRSCH, EC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (21) : 9603 - 9607
  • [10] Ferger B, 1998, J NEUROCHEM, V70, P276